Baxalta

GAMMAGARD S-D

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Baxalta

Gammagard S-D HCPCS:

J1566

HCPCS Code Descriptor:

Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg

Category:

J Code

Gammagard S-D NDCs:

00944-2656-03, 00944-2658-04

Primary Type:

Immunoglobulin

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Gammagard S-D CPT Codes:

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have not identified any potential errors with the NDCs mapped to this HCPCS code.

About Gammagard S-D:

GAMMAGARD S-D is an Immunoglobulin drug manufactured by Baxalta and administered via the Intravenous route of administration. The J Code: J1566 is aligned to the drug GAMMAGARD S-D.

Gammagard S/D is used to help protect people with weakened immune systems by increasing platelet count. Gammagard S/D can also be used to treat certain cases of muscle weakness, certain nerve disorders, and blood vessel disorders. Gammagard S/D is administered as an intravenous injection of human blood that contains a high level of antibodies. Gammagard Liquid, is a different product than Gammagard S/D. Gammagard S/D is mapped to the HCPCS J1566 while Gammagard Liquid is mapped to the HCPCS J1569. The product monograph for Gammagard S/D can be found through Takeda.

ACCESS PRICING AND MORE BY REGISTERING

J1566 Added Date:

January 1, 2006

J1566 Effective Date:

January 1, 2008

J1566 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Gammagard S-D billing and coding information.
Our team did not identify a source for Gammagard S-D patient assistance information. Please reach out to our team if you feel that this is a mistake.
GAMMAGARD S-D prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for GAMMAGARD S-D. Please check back in a few weeks.